Treatment of Refractory Schizophrenia With Riluzole
Condition(s):Schizophrenia; SchizoaffectiveLast Updated:December 9, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Schizophrenia; SchizoaffectiveLast Updated:December 9, 2019Completed
Condition(s):Melanoma (Skin)Last Updated:January 19, 2024Completed
Condition(s):Hereditary Ataxia; Multiple Sclerosis; Cerebellar AtaxiaLast Updated:February 11, 2014Completed
Condition(s):Bipolar DisorderLast Updated:April 25, 2019Terminated
Condition(s):Bipolar DisorderLast Updated:April 11, 2017Completed
Condition(s):Bipolar Disorder; Anxiety Disorders; Bipolar Affective Disorder; Bipolar DepressionLast Updated:September 15, 2017Terminated
Condition(s):Amyotrophic Lateral SclerosisLast Updated:February 25, 2020Completed
Condition(s):Alzheimer’s DiseaseLast Updated:September 22, 2021Completed
Condition(s):Multiple SclerosisLast Updated:April 9, 2014Completed
Condition(s):Amyotrophic Lateral SclerosisLast Updated:October 11, 2007Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.